New EMA policy on access to documents still falls short, say campaignersBMJ 2017; 357 doi: https://doi.org/10.1136/bmj.j2444 (Published 18 May 2017) Cite this as: BMJ 2017;357:j2444
- Jacqui Wise
Proposed changes to the way the European Medicines Agency allows access to documents it holds are still too restrictive, warn campaigners.
The EMA launched a public consultation on the revision to its policy on access to documents, which invited stakeholders to comment by 18 May 2017.1
A coalition of organisations—Health Action International, the International Society of Drug Bulletins, NoGracias, the Nordic Cochrane Centre, and the journal Prescrire—said that the revised policy falls short on proactive disclosure.2
In a joint response they raised the concern that …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial